FindTrial
Sign In

The study on diagnosis and treatment of hematological diseases

The application of genetic/molecular markers in the diagnosis and treatment of acute leukemia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RNC-14004969
Enrollment
Unknown
Registered
2014-07-17
Start date
2008-08-11
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute leukemia

Interventions

Case series:N/A

Sponsors

Rui Jin hospital affiliated to Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 85 Years

Inclusion criteria

Inclusion criteria: Male or female, 14-85 years old; newly diagnosed acute leukemia;signed informed consent.

Exclusion criteria

Exclusion criteria: History of other cancers, except basal cell carcinoma; with contraindications of corticosteroids; history of severe heart diseases; diabetes which cannot be successfully controlled; HIV and syphilis; pregnancy or lactating women; patients previously received an organ transplantation; severe neurological or psychiatric history.

Design outcomes

Primary

MeasureTime frame
Overall survival;Relapse-free survival;Event-free survival;Complete remissio;—

Countries

China

Contacts

Public ContactSaijuan Chen, Jianqing Mi
jianqingmi@shsmu.edu.cn+86 021-64370045-601803

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026